EIKN (EIKN) Stock Price & Analysis
EIKN (EIKN) fell 0.91% to USD 10.86 as of September 8, 2026 at 09:10 UTC, according to Nexqual real-time market data.
EIKN last closed at USD 10.86; the session ranged USD 10.62–11.05 on volume of 238,698 shares. Market capitalization is —, with a 52-week range of USD 7.9–17.4 (NMS). Source: Nexqual, September 8, 2026 at 09:10 UTC.
Key Statistics (as of September 8, 2026 at 09:10 UTC)
| Price | USD 10.86 |
|---|---|
| Change | ▼ 0.91% (down) |
| Previous Close | USD 10.86 |
| Open | USD 10.86 |
| Day Range | USD 10.62 – 11.05 |
| 52-Week Range | USD 7.9 – 17.4 |
| Volume | 238,698 shares |
| Market Cap | — |
| Exchange | NMS |
Technical Analysis (EIKN)
Nexqual's technical model rates EIKN "BUY" based on 4 bullish and 2 bearish signals across 128 daily candles, as of September 8, 2026 at 09:10 UTC.
| Overall Signal | BUY |
|---|---|
| RSI (14) | 50.18 (neutral) |
| vs SMA50 | Above (USD 10.62) |
| MACD | 0.23 (positive) |
From EIKN's Latest SEC 10-K Filing (filed 2026-03-30)
Source: SEC EDGAR 10-K. Curated by Nexqual.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| AGMB | AgomAb Therapeutics NV | USD 15.78 | ▲ 15.52% |
| KLRA | Kailera Therapeutics, Inc. | USD 16.23 | ▲ 2.4% |
| COAG | Hemab Therapeutics Holdings, In | USD 44.41 | ▼ 0.65% |
| EVMN | Evommune, Inc. | USD 12.27 | ▼ 1.68% |
| SPTX | Seaport Therapeutics, Inc. | USD 24.86 | ▼ 0.2% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: September 8, 2026 at 09:10 UTC. This page is informational and not investment advice.